Skip to content

Faculty profile

Lois Mulligan

Back to faculty
ResearcherCancer Research InstituteQueen's University

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Queen's University directory, so their courses and email address may be missing. Find their university profile.

Latest papers

  • Cargo-selective regulation of clathrin-mediated endocytosis by AMP-activated protein kinase.

    iScience · 2025

  • Selective RET Kinase Inhibitors and Lung Cancer.

    The New England journal of medicine · 2023 · first author

  • A comprehensive review on MEN2B.

    Endocrine-related cancer · 2018

All 4 publications

Latest funding

  • Exploring molecular mechanisms underlying RET-regulated cell invasion

    CIHR · 2026 · Supervisor

    $6,000
  • Exploring RET-mediated pathways regulating cancer cell growth

    CIHR · 2025 · Supervisor

    $6,000
  • Investigating the role of RET in invasion of pancreatic ductal adenocarcinoma cells

    CIHR · 2024 · Supervisor

    $6,000
All 7 grants and awards
Something wrong or missing on this profile? Suggest a correction